• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HER2 表达定义了 EGFR 信号传导中浮游蛋白和 c-Src 的独特要求。

HER2 expression defines unique requirements for flotillin and c-Src in EGFR signaling.

机构信息

Department of Chemistry and Biology, Toronto Metropolitan University, Toronto, ON, M5B 2K3, Canada.

Graduate Program in Molecular Science, Toronto Metropolitan University, Toronto, ON, M5B 2K3, Canada.

出版信息

J Cell Sci. 2023 Apr 1;136(7). doi: 10.1242/jcs.260133. Epub 2023 Mar 27.

DOI:10.1242/jcs.260133
PMID:36727482
Abstract

The epidermal growth factor receptor (EGFR) controls many cellular functions. Upon binding its ligand, the receptor undergoes dimerization, phosphorylation and activation of signals including the phosphoinositide-3-kinase (PI3K)-Akt pathway. Although some studies have indicated that EGFR signaling may be controlled by signal enrichment within various membrane rafts, such as flotillin nanodomains, others have found a limited effect of disruption of these nanodomains on EGFR signaling, suggesting that specific factors may define context-specific control of EGFR signaling. Ligand-bound EGFR can homodimerize or instead undergo heterodimerization with the related receptor HER2 (also known as ERBB2) when the latter is expressed. We examined how EGFR signaling in the presence of HER2 distinctly requires flotillin nanodomains. Induction of HER2 expression altered EGFR signaling duration, which is consistent with EGFR-HER2 heterodimer formation. EGFR and c-Src (also known as SRC) localized within plasma membrane structures demarked by flotillin-1 more prominently in HER2-expressing cells. Consistently, HER2-expressing cells, but not cells lacking HER2, were dependent on flotillin-1 and c-Src for EGFR signaling leading to Akt activation and cell proliferation. Hence, HER2 expression establishes a requirement for flotillin membrane rafts and c-Src in EGFR signaling.

摘要

表皮生长因子受体 (EGFR) 控制着许多细胞功能。在与其配体结合后,受体发生二聚化、磷酸化,并激活包括磷酸肌醇-3-激酶 (PI3K)-Akt 途径在内的信号通路。尽管一些研究表明,EGFR 信号可能受到各种膜筏(如 flotillin 纳米域)内信号富集的控制,但其他研究发现破坏这些纳米域对 EGFR 信号的影响有限,这表明特定因素可能定义 EGFR 信号的特定上下文控制。当后者表达时,配体结合的 EGFR 可以与相关受体 HER2(也称为 ERBB2)发生同源二聚化或异源二聚化。我们研究了 HER2 存在时 EGFR 信号如何明显需要 flotillin 纳米域。HER2 表达的诱导改变了 EGFR 信号的持续时间,这与 EGFR-HER2 异源二聚体的形成一致。在表达 HER2 的细胞中,EGFR 和 c-Src(也称为 SRC)定位于 flotillin-1 标记的质膜结构中更为明显。一致地,表达 HER2 的细胞而不是缺乏 HER2 的细胞依赖 flotillin-1 和 c-Src 进行 EGFR 信号传导,导致 Akt 激活和细胞增殖。因此,HER2 表达建立了 flotillin 膜筏和 c-Src 在 EGFR 信号传导中的需求。

相似文献

1
HER2 expression defines unique requirements for flotillin and c-Src in EGFR signaling.HER2 表达定义了 EGFR 信号传导中浮游蛋白和 c-Src 的独特要求。
J Cell Sci. 2023 Apr 1;136(7). doi: 10.1242/jcs.260133. Epub 2023 Mar 27.
2
ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells.ERBB3(HER3)是调节低表达和高表达 ERBB2(HER2)的癌细胞中 ERBB 介导信号转导的关键传感器。
Cancer Med. 2012 Aug;1(1):28-38. doi: 10.1002/cam4.10. Epub 2012 Jul 15.
3
Flotillin-1/reggie-2 protein plays dual role in activation of receptor-tyrosine kinase/mitogen-activated protein kinase signaling. flotillin-1/reggie-2 蛋白在受体酪氨酸激酶/丝裂原活化蛋白激酶信号转导的激活中发挥双重作用。
J Biol Chem. 2012 Mar 2;287(10):7265-78. doi: 10.1074/jbc.M111.287599. Epub 2012 Jan 9.
4
A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.一种新的模型系统将表皮生长因子受体-人表皮生长因子受体2(HER2)以及HER2-人表皮生长因子受体3异二聚体识别为食管上皮细胞侵袭的强效诱导剂。
J Pathol. 2017 Dec;243(4):481-495. doi: 10.1002/path.4987. Epub 2017 Nov 5.
5
Heterodimerization of c-erbB2 with different epidermal growth factor receptor mutants elicits stimulatory or inhibitory responses.c-erbB2与不同的表皮生长因子受体突变体的异源二聚化引发刺激或抑制反应。
J Biol Chem. 1992 Apr 25;267(12):8056-63.
6
Anti-epidermal growth factor receptor monoclonal antibody cetuximab inhibits EGFR/HER-2 heterodimerization and activation.抗表皮生长因子受体单克隆抗体西妥昔单抗可抑制表皮生长因子受体/人表皮生长因子受体2异源二聚化及激活。
Int J Oncol. 2009 Jan;34(1):25-32.
7
Src family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cells.Src 家族激酶介导乳腺癌细胞脂筏中表皮生长因子受体信号转导。
Cancer Biol Ther. 2011 Oct 15;12(8):718-26. doi: 10.4161/cbt.12.8.16907.
8
Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton.转化生长因子β通过激活Src-粘着斑激酶以及受体与细胞骨架的结合,诱导HER2和整合素聚集。
Cancer Res. 2009 Jan 15;69(2):475-82. doi: 10.1158/0008-5472.CAN-08-2649.
9
Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor.多巴胺D2受体介导的磷酸肌醇3-激酶信号通路的激动剂特异性反式激活
J Biol Chem. 2003 Nov 21;278(47):47053-61. doi: 10.1074/jbc.M303364200. Epub 2003 Sep 11.
10
ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells.ZD1839是一种特异性表皮生长因子受体(EGFR)酪氨酸激酶抑制剂,可诱导无活性的EGFR/HER2和EGFR/HER3异二聚体形成,并阻止HER2过表达乳腺癌细胞中的这里调节蛋白信号传导。
Clin Cancer Res. 2003 Apr;9(4):1274-83.

引用本文的文献

1
Cargo-selective regulation of clathrin-mediated endocytosis by AMP-activated protein kinase.AMP激活的蛋白激酶对网格蛋白介导的内吞作用的货物选择性调节。
iScience. 2025 Jul 17;28(8):113131. doi: 10.1016/j.isci.2025.113131. eCollection 2025 Aug 15.
2
Lipid rafts: novel therapeutic targets for metabolic, neurodegenerative, oncological, and cardiovascular diseases.脂筏:代谢性、神经退行性、肿瘤性和心血管疾病的新型治疗靶点。
Lipids Health Dis. 2025 Apr 17;24(1):147. doi: 10.1186/s12944-025-02563-0.
3
HER2-positive gastric cancer: from targeted therapy to CAR-T cell therapy.
人表皮生长因子受体2阳性胃癌:从靶向治疗到嵌合抗原受体T细胞疗法
Front Immunol. 2025 Mar 13;16:1560280. doi: 10.3389/fimmu.2025.1560280. eCollection 2025.
4
Confinement of unliganded EGFR by tetraspanin nanodomains gates EGFR ligand binding and signaling.四跨膜蛋白纳米域对无配体 EGFR 的限制控制 EGFR 配体结合和信号转导。
Nat Commun. 2023 May 9;14(1):2681. doi: 10.1038/s41467-023-38390-z.